Back Pain Lower Back Chronic Clinical Trial
Official title:
Structural Integration for Chronic Low Back Pain
The primary purpose of study is the collection of feasibility data for a larger trial of Structural Integration (SI)(an alternative manual therapy) for chronic low back pain. The secondary purpose is the collection of preliminary data on 1) the therapeutic effect of SI plus usual care versus usual care alone - the hypothesis being the the effect size will be significantly greater in the SI plus usual care arm; and on 2) specific hypothesized mechanisms of that hypothesized therapeutic effect: a) improvements in cognitive behavioral factors; b) improvements in standing balance and gait, and c) improvements in selected blood biomarkers.
Chronic, non-specific low back pain is among the most burdensome health problems in both
prevalence and cost of care. Up to one third of acute low back pain cases may become chronic
and lead to disability. A large fraction of chronic cases are absent of findings of
well-understood causes, i.e. neoplastic, infectious or inflammatory conditions, or nerve
compression, and are generally designated as "uncomplicated," "non-specific," or
"mechanical." Usual care typically includes oral and injected medication, physical therapy
and exercise. Therapeutic response is difficult to predict and many outcomes are
unsatisfactory, with high rates of relapse.
Structural Integration (SI) is an alternative method of manual therapy and somato-sensory
training that purports to improve the biomechanical functioning of the body as a whole
rather than to focus on the treatment of specific symptoms. SI is delivered in a series of
ten treatments, referred to as "the Ten Series," each of approximately one hour in duration.
The Ten Series protocol includes manipulation of all major joints and anatomical segments.
Each of the ten sessions aims to achieve a different, specified set of biomechanical changes
which are regarded as contributing to the progressive approximation of specific ideals of
posture and movement.
Forty (40) subjects will be recruited from among individuals entering treatment for chronic
low back pain at outpatient rehabilitation clinics in the Boston area. Following baseline
measures, subjects will be randomized with equal probability (50/50) to usual care alone
versus usual care plus ten sessions of SI. SI treatment will be provided by qualified SI
therapists at their private practice offices. They will be supervised on a monthly basis by
a co-investigator with extensive prior experience in the clinical practice of SI.
Data will be collected at baseline, end-of-treatment, and endpoint. Baseline data will be
collected prior to the subject's first treatment appointment, and endpoint data will be
collected from all subjects at 20 weeks post-baseline. End-of-treatment measures will be
conducted during the week following each subject's completion of their assigned treatment
arm. Consequently, the average time elapsed between baseline and end-of-treatment will
differ across the two treatment arms, because of different amounts of time allowed for the
completion of usual care alone (3-7 weeks) versus usual care plus SI (10-15) weeks.
Analysis relevant to the primary aim of the study will be conducted as follows: The
demographic characteristics of candidates referred, subjects enrolled, and dropouts will
described. Descriptive statistics, both aggregate and per treatment arm, will be computed
for data on retention and compliance with treatment, and on the use of concurrent
medications. Each adverse events will be characterized by subject demographics and by
treatment arm, and will also be rated for severity, likelihood of relation to the study, and
expected versus unexpected.
Analysis relevant to the secondary aim of the study will be conducted as follows: Baseline
to endpoint changes in therapeutic outcomes, cognitive-behavioral measures and blood assay
values will be compared across treatment arms using appropriate statistical tests. Baseline
to endpoint changes in standing balance and gait parameters will be analyzed using methods
that are standard in the current literature. In addition to appropriate statistical tests,
these include the visual inspection of graphic displays of the phase relationships between
rotational movements of body segments during gait. The association between each mechanistic
parameter - cognitive-behavioral, biomechanical, and blood biomarkers - and the primary and
secondary therapeutic outcomes will be explored per treatment arm and in aggregate.
Data on changes between baseline and end-of-treatment will be subject to exploratory
analysis within treatment arms only. Comparison across arms is inappropriate because of
systematic variation in the average duration of treatment in usual care alone (estimated at
5 weeks) versus usual care plus SI (estimated at 12.5 weeks). Analysis will include the
exploration of associations between changes in therapeutic outcomes on one hand, and
mechanistic parameters on the other, but only within each treatment arm.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01914666 -
An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT01761617 -
Yoga Dosing Study for Chronic Low Back Pain
|
N/A | |
Completed |
NCT03338192 -
Examining Racial and SocioEconomic Disparities (ERASED) in Chronic Low Back Pain Study
|
||
Completed |
NCT03106740 -
Evaluating the Role of Neuroinflammation in Low Back Pain
|
Phase 2 | |
Completed |
NCT02960269 -
Interprofessional Management of Chronic Back Pain in Rural and Remote Setting: Use of Telehealth vs. Secure Laptop-based Videoconferencing
|
N/A | |
Completed |
NCT04203888 -
Personalized Trial for Chronic Lower Back Pain
|
N/A | |
Not yet recruiting |
NCT05704751 -
EVOKE ECAP-Controlled Lead Placement and Programming in Chronic Pain Patients
|
||
Completed |
NCT06351774 -
Project AdaPT: An Adaptive Physiotherapy Intervention Augmented With a Healthy Mind Training Program for People With Chronic Low Back Pain
|
N/A | |
Completed |
NCT01855919 -
A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain
|
Phase 3 | |
Terminated |
NCT01865539 -
Efficacy of Foot Orthotics in Veterans With Chronic Lower Back Pain
|
N/A | |
Enrolling by invitation |
NCT05386212 -
The Impact of an Instructional Web-based Healthcare App for Relieving Back Pain From Spinal Compression Fractures
|
||
Completed |
NCT03299192 -
Tai Chi for Chronic Low Back Pain in Older Adults
|
N/A | |
Completed |
NCT01081912 -
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT04468074 -
Virtual Reality Treatment for Adults With Chronic Back Pain
|
N/A | |
Completed |
NCT01343927 -
Yoga vs. Physical Therapy vs. Education for Chronic Low Back Pain in Minority Populations
|
N/A | |
Completed |
NCT01329861 -
Internet-based Cognitive Behavioural Treatment for Chronic Back Pain
|
N/A | |
Terminated |
NCT01125917 -
Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015
|
Phase 3 | |
Enrolling by invitation |
NCT05413070 -
Quality Improvement re: Choosing Wisely Back Pain Measures
|
||
Not yet recruiting |
NCT06401499 -
The Effect of Pregabalin and Etoricoxib on Pain Alone Versus in Combination
|
Phase 4 | |
Recruiting |
NCT04893720 -
The SPINUS II Study: Spinal Fusion for Multilevel SPECT/CT Positive Lumbar Degeneration
|